A limited infiltration and the subsequent low effective drug concentration result in poor
chemotherapeutic outcomes against tumors, and even further promote tumor resistance and …

Tumor microenvironment (TME) featured by dense extracellular matrix (ECM), high
interstitial pressure, hypoxia, and immunosuppression hinders the infiltration of …

Biofunctional surface-modification surpassed critical limitation of graphene oxide (GO) in
biocompatibility and drug delivery efficiency, contributing to versatile biomedical …

Although metastatic cancer treatment has advanced in current medicine, finding effective
treatments remains challenging due to the metastatic mechanism complexity. The integrity of …

Purpose To develop a multi-functional theranostic nanoplatform with increased tumor
retention, improving antitumor efficacy and decreased side effects of chemotherapy drugs …

We used reduced graphene oxide (rGO), which has two times higher photothermal
conversion efficiency than graphene oxide (GO), as a photothermal agent for cancer …

Herein, we design a rGO-based magnetic nanocomposite by decorating rGO with citrate-
coated magnetic nanoparticles (CMNP). The magnetic rGO (mrGO) was modified by …

Purpose Graphene oxide (GO) and its derivatives have recently been identified as promising
candidates for early disease diagnosis and therapy. However, the physiological stability and …

Despite the tremendous progress that photothermal therapy (PTT) has recently achieved, it
still has a long way to go to gain the effective targeted photothermal ablation of tumor cells …

Dual-targeted delivery of drugs and energy by nanohybrids can potentially alleviate side
effects and improve the unique features required for precision medicine. To realize this aim …